ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER

Peak

esmolol hydrochloride

R-Pharm US
NDAINTRAVENOUSSOLUTION
Approved
Apr 2016
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

12.1 Mechanism of Action Esmolol hydrochloride is a beta 1 -selective (cardioselective) adrenergic receptor blocking agent with rapid onset, a very short duration of action, and no significant intrinsic sympathomimetic or membrane stabilizing activity at therapeutic dosages. Its elimination…

Indications (6)

noncompensatory sinus tachycardia wherethe physician's judgmentthe rapid heart rate requires specific interventionhypertensionatrial fibrillationsuch events is not recommended

Loss of Exclusivity

LOE Date
Mar 15, 2033
85 months away
Patent Expiry
Mar 15, 2033

Patent Records (2)

Patent #ExpiryTypeUse Code
8829054
Mar 15, 2033
Product
—
8835505
Mar 15, 2033
Product
—
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers